Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Fast-Tracking FIH To PoC: Strategies For Accelerated Drug Development
Three factors often decide success or failure in FIH studies: integrating biomarkers and pharmacodynamic endpoints, including patients in the trials, and leveraging purpose-built manufacturing infrastructure.
-
Matrix Approach Enhances Potency Assay Development For ATMPs
Potency assays for ATMPs demand precision. Learn how a matrix approach, regulatory alignment, and advanced technologies can overcome variability and ensure safety throughout the product lifecycle.
-
Doubling Up For Speed In Biomanufacturing
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
How To Reduce Batch Loss In Biopharma Production
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
CDMOs - Key Collaborators In Streamlining Drug Development
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Using DSC And MDSC To Study Material Interactions Of APIs And Excipients
Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.
-
Remote Measurements For Bulk Samples
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Lentiviral Vector Upstream Process
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Aggregate Analysis Of Semaglutide
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
FORMULATION DEVELOPMENT SOLUTIONS
- Cell Culture Media For Viral Vector Production
- Continuous Flow
- Bioprocess Courses And Services
- ADC And Bioconjugation Center Of Excellence
- Multi-Mode Microplate Reader
- Microcalorimetry: RS-DSC, DSC & ITC
- The Power Of One: mRNA Services
- R&D And Analytical Services
- The Buyer's Guide To Buffer Formulation Equipment
- The Digital Suite For Process Lifecycle Intelligence
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- INTERPHEX Opens Registration For 2026 With Expanded Show Floor, Education And Debut Of New Contract & Outsourcing Hub
- AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services
- Johnson & Johnson Announces Plans For New Manufacturing Facilities In North Carolina And Pennsylvania
- Sharp Sterile Manufacturing Increases Capacity With $28 Million Investment Featuring New IMA Isolated Vial Filling Line
- CDMO GBI Biomanufacturing Announces New President
- Symbiosis Initiates Commercial Drug Manufacturing At New FDA-Inspected Production Facility
- Samsung Biologics Expands U.S. Manufacturing Capabilities With Strategic Acquisition Of Human Genome Sciences From GSK
- Techceuticals Releases 2026 Schedule For In-Person Solid Dosage Manufacturing Training
- Sanofi Toronto Equipment Assets Auction Announced For January 2026
- Alnylam Announces $250M Investment To Expand U.S. Manufacturing Capacity In Massachusetts For RNAi Therapeutics